MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo.


Journal

Cell stem cell
ISSN: 1875-9777
Titre abrégé: Cell Stem Cell
Pays: United States
ID NLM: 101311472

Informations de publication

Date de publication:
04 04 2019
Historique:
received: 10 11 2017
revised: 24 12 2018
accepted: 30 01 2019
pubmed: 12 3 2019
medline: 19 5 2020
entrez: 12 3 2019
Statut: ppublish

Résumé

Heart disease is a paramount cause of global death and disability. Although cardiomyocyte death plays a causal role and its suppression would be logical, no clinical counter-measures target the responsible intracellular pathways. Therapeutic progress has been hampered by lack of preclinical human validation. Mitogen-activated protein kinase kinase kinase kinase-4 (MAP4K4) is activated in failing human hearts and relevant rodent models. Using human induced-pluripotent-stem-cell-derived cardiomyocytes (hiPSC-CMs) and MAP4K4 gene silencing, we demonstrate that death induced by oxidative stress requires MAP4K4. Consequently, we devised a small-molecule inhibitor, DMX-5804, that rescues cell survival, mitochondrial function, and calcium cycling in hiPSC-CMs. As proof of principle that drug discovery in hiPSC-CMs may predict efficacy in vivo, DMX-5804 reduces ischemia-reperfusion injury in mice by more than 50%. We implicate MAP4K4 as a well-posed target toward suppressing human cardiac cell death and highlight the utility of hiPSC-CMs in drug discovery to enhance cardiomyocyte survival.

Identifiants

pubmed: 30853557
pii: S1934-5909(19)30013-X
doi: 10.1016/j.stem.2019.01.013
pmc: PMC6458995
pii:
doi:

Substances chimiques

Intracellular Signaling Peptides and Proteins 0
Doxorubicin 80168379AG
Hydrogen Peroxide BBX060AN9V
MAP4K4 protein, human EC 2.7.1.11
Protein Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

579-591.e12

Subventions

Organisme : British Heart Foundation
ID : SI/11/2/28875
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 205256/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0901467
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/08/002
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT10638
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC PC 12015
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT205256
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/08/007
Pays : United Kingdom
Organisme : European Research Council
ID : 233158
Pays : International
Organisme : British Heart Foundation
ID : CH/08/002/29257
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Cell. 2006 Jun 2;125(5):957-69
pubmed: 16751104
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
Circ Cardiovasc Imaging. 2014 Mar;7(2):240-9
pubmed: 24425501
J Biol Chem. 1999 Jan 22;274(4):2118-25
pubmed: 9890973
Circ Res. 2017 Apr 28;120(9):1487-1500
pubmed: 28450366
EMBO J. 2004 Sep 1;23(17):3559-69
pubmed: 15297879
Biochem Pharmacol. 2017 Aug 15;138:140-149
pubmed: 28522407
J Signal Transduct. 2013;2013:956580
pubmed: 24163766
Science. 2007 Sep 7;317(5843):1393-7
pubmed: 17717153
Carcinogenesis. 2014 Mar;35(3):613-23
pubmed: 24233838
Sci Transl Med. 2014 Jun 4;6(239):239ps6
pubmed: 24898747
Nature. 2018 Aug;560(7720):655-660
pubmed: 30135582
Nat Genet. 2005 Nov;37(11):1281-8
pubmed: 16200065
J Am Heart Assoc. 2017 Jul 28;6(8):
pubmed: 28754655
Sci Transl Med. 2013 Aug 7;5(197):197ra103
pubmed: 23926201
Regen Eng Transl Med. 2018 Sep;4(3):142-153
pubmed: 30393757
Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:83-103
pubmed: 28992430
Cell Rep. 2018 Sep 25;24(13):3582-3592
pubmed: 30257217
Science. 2010 Oct 22;330(6003):517-21
pubmed: 20966255
J Neurosci. 2017 Nov 15;37(46):11074-11084
pubmed: 28993483
Nat Med. 2000 May;6(5):556-63
pubmed: 10802712
N Engl J Med. 2008 Jul 31;359(5):473-81
pubmed: 18669426
Cell Rep. 2015 Oct 27;13(4):733-745
pubmed: 26489474
N Engl J Med. 2010 Oct 7;363(15):1397-409
pubmed: 20660394
J Cardiovasc Pharmacol. 2000 Mar;35(3):474-83
pubmed: 10710135
Biochem J. 2007 Dec 15;408(3):297-315
pubmed: 17850214
J Biol Chem. 2004 Jul 2;279(27):28585-91
pubmed: 15100233
J Gen Physiol. 2017 Dec 4;149(12):1065-1089
pubmed: 29122978
Trends Cell Biol. 2001 May;11(5):220-30
pubmed: 11316611
Cancer Res. 2014 May 1;74(9):2377-84
pubmed: 24717177
Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14495-500
pubmed: 16983089
Circ Res. 2018 May 11;122(10):1460-1478
pubmed: 29748369
Curr Top Dev Biol. 2014;109:171-247
pubmed: 24947238
PLoS One. 2011;6(10):e26397
pubmed: 22028871
Cold Spring Harb Perspect Med. 2014 Jun 02;4(6):
pubmed: 24890831
EMBO Mol Med. 2015 Feb 19;7(4):394-410
pubmed: 25700171
Dis Model Mech. 2015 May;8(5):457-66
pubmed: 25791035
Sci Rep. 2015 Mar 09;5:8883
pubmed: 25748532
Cardiovasc Res. 2005 Feb 1;65(2):469-77
pubmed: 15639486
Nat Protoc. 2017 Jun;12(6):1177-1197
pubmed: 28492526
Lancet. 2013 Jan 12;381(9861):166-75
pubmed: 23095318
Circulation. 2001 Aug 14;104(7):826-31
pubmed: 11502710
Sci Transl Med. 2017 Feb 15;9(377):
pubmed: 28202772
Cell Stem Cell. 2016 Sep 1;19(3):311-25
pubmed: 27545504
Lancet. 2014 Sep 27;384(9949):1187-95
pubmed: 24930728
J Am Coll Cardiol. 2016 Feb 2;67(4):365-374
pubmed: 26821623
Nat Methods. 2014 Aug;11(8):855-60
pubmed: 24930130
J Biol Chem. 1991 Dec 25;266(36):24613-20
pubmed: 1722208
Circulation. 2013 Oct 1;128(14):1495-503
pubmed: 24002794
Exp Neurol. 2012 Sep;237(1):238-45
pubmed: 22683931
Nature. 2018 Apr;556(7700):239-243
pubmed: 29618819
Nat Rev Mol Cell Biol. 2012 Nov;13(11):713-26
pubmed: 23034453
Circulation. 1998 Apr 21;97(15):1488-95
pubmed: 9576430
Sci Rep. 2017 Jul 14;7(1):5464
pubmed: 28710467
Circulation. 2013 Apr 23;127(16):1677-91
pubmed: 23519760
Nature. 2011 Mar 10;471(7337):230-4
pubmed: 21307850
Curr Comput Aided Drug Des. 2011 Sep 1;7(3):190-205
pubmed: 21726191
Cancer Res. 2005 Jun 15;65(12):5096-104
pubmed: 15958553
Dev Biol. 2008 Dec 15;324(2):245-57
pubmed: 18840424
J Biol Chem. 2004 Nov 19;279(47):49488-96
pubmed: 15342639
J Biol Chem. 2008 May 2;283(18):11964-71
pubmed: 18310079
J Cardiovasc Transl Res. 2011 Feb;4(1):66-72
pubmed: 21061105
Circ Res. 2015 Jan 30;116(3):531-49
pubmed: 25634975
Mol Biol Cell. 2009 Aug;20(16):3628-37
pubmed: 19570911
Cell Stem Cell. 2017 Jul 6;21(1):14-17
pubmed: 28686863
Chem Biol. 2011 Jun 24;18(6):699-710
pubmed: 21700206
APL Bioeng. 2018 Mar 20;2(2):026102
pubmed: 31069299
J Am Coll Cardiol. 2015 Apr 21;65(15):1567-82
pubmed: 25881939
Nat Rev Cardiol. 2009 Apr;6(4):283-91
pubmed: 19352332
Cell Stem Cell. 2013 Jun 6;12(6):713-26
pubmed: 23602540
Circ Res. 2010 Jul 9;107(1):35-44
pubmed: 20448218
Development. 2001 May;128(9):1559-72
pubmed: 11290295
Annu Rev Physiol. 2010;72:19-44
pubmed: 20148665
Dev Cell. 2014 Dec 8;31(5):572-85
pubmed: 25490267
J Pharmacol Exp Ther. 2018 Jan;364(1):87-96
pubmed: 29101218
Eur Heart J. 2014 Oct 1;35(37):2516-23
pubmed: 24796339
N Engl J Med. 2015 Sep 10;373(11):1073-5
pubmed: 26321104
Am J Physiol. 1999 Aug;277(2 Pt 2):H660-8
pubmed: 10444492
Nature. 2015 Mar 26;519(7544):425-30
pubmed: 25799996
Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H2006-17
pubmed: 21890694
Anticancer Agents Med Chem. 2016;16(8):1017-1030
pubmed: 26961313
Br J Pharmacol. 2017 Nov;174(21):3749-3765
pubmed: 27641943
Science. 2015 Aug 28;349(6251):982-6
pubmed: 26315439
Nat Med. 2016 May;22(5):547-56
pubmed: 27089514
Lancet. 2017 Sep 16;390(10100):1260-1344
pubmed: 28919118
J Biol Chem. 2011 Aug 5;286(31):27582-93
pubmed: 21622575
Science. 2007 Dec 21;318(5858):1917-20
pubmed: 18029452
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5378-83
pubmed: 12702777
EMBO J. 1997 Mar 17;16(6):1279-90
pubmed: 9135144

Auteurs

Lorna R Fiedler (LR)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

Kathryn Chapman (K)

Drug Discovery Centre, Department of Medicine, Imperial College London, London SW7 2AZ, UK; Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK; Domainex, Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL, UK.

Min Xie (M)

Michael E. DeBakey Heart Center, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

Evie Maifoshie (E)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

Micaela Jenkins (M)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

Pelin Arabacilar Golforoush (PA)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

Mohamed Bellahcene (M)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

Michela Noseda (M)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

Dörte Faust (D)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

Ashley Jarvis (A)

Domainex, Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL, UK.

Gary Newton (G)

Domainex, Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL, UK.

Marta Abreu Paiva (MA)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

Mutsuo Harada (M)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

Daniel J Stuckey (DJ)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

Weihua Song (W)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

Josef Habib (J)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

Priyanka Narasimhan (P)

Domainex, Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL, UK.

Rehan Aqil (R)

Domainex, Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL, UK.

Devika Sanmugalingam (D)

Domainex, Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL, UK.

Robert Yan (R)

Domainex, Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL, UK.

Lorenzo Pavanello (L)

Domainex, Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL, UK.

Motoaki Sano (M)

Michael E. DeBakey Heart Center, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

Sam C Wang (SC)

Michael E. DeBakey Heart Center, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

Robert D Sampson (RD)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

Sunthar Kanayaganam (S)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

George E Taffet (GE)

Michael E. DeBakey Heart Center, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

Lloyd H Michael (LH)

Michael E. DeBakey Heart Center, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

Mark L Entman (ML)

Michael E. DeBakey Heart Center, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

Tse-Hua Tan (TH)

Immunology Research Center, National Health Research Institutes, Zhunan 35053, Taiwan; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.

Sian E Harding (SE)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK.

Caroline M R Low (CMR)

Drug Discovery Centre, Department of Medicine, Imperial College London, London SW7 2AZ, UK.

Catherine Tralau-Stewart (C)

Drug Discovery Centre, Department of Medicine, Imperial College London, London SW7 2AZ, UK.

Trevor Perrior (T)

Domainex, Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL, UK.

Michael D Schneider (MD)

British Heart Foundation Centre of Research Excellence, National Heart and Lung Institute, Imperial College London, London W12 0NN, UK; Michael E. DeBakey Heart Center, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address: m.d.schneider@imperial.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH